HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of xamoterol in Shy-Drager syndrome.

AbstractBACKGROUND:
Xamoterol, a cardioselective beta 1-adrenoceptor partial agonist, has been reported to be effective on postural hypotension. We investigated the effect of xamoterol in five patients with Shy-Drager syndrome (SDS) in relation to their prevailing sympathetic nerve activity and sensitivity of beta-adrenoceptors and the change in circadian variation of blood pressure.
METHODS AND RESULTS:
Ambulatory blood pressure over 24 hours was monitored by noninvasive sphygmomanometer (model 5200, Spacelab). Plasma norepinephrine levels of SDS patients were significantly lower than that of normal subjects (n = 5) both at rest (54 +/- 15 versus 178 +/- 83 pg/ml) and after 10-minute standing (74 +/- 24 versus 318 +/- 143 pg/ml). Infusion of isoproterenol (0.02 micrograms/kg/min) produced a mild rise of systolic blood pressure and tachycardia in normal subjects but resulted in marked hypotension and tachycardia in SDS subjects. After xamoterol administration (200 mg b.i.d.), systolic blood pressure and heart rate were significantly increased in the averages during the day; however, increases were more pronounced at night. In two of the five patients, the improvement in dizziness was large enough to enable them to increase their daily activities.
CONCLUSIONS:
Our observations suggest that 1) beta 1-selective, high intrinsic sympathomimetic activity of xamoterol increases blood pressure and heart rate in patients with SDS as a consequence of their prevailing beta 1-adrenoceptor hypersensitive state, and 2) blood pressure monitoring over 24 hours appears to have important advantages in evaluating the therapeutic effects on postural hypotension.
AuthorsA Obara, H Yamashita, S Onodera, O Yahara, H Honda, N Hasebe
JournalCirculation (Circulation) Vol. 85 Issue 2 Pg. 606-11 (Feb 1992) ISSN: 0009-7322 [Print] United States
PMID1346511 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Adrenergic beta-Agonists
  • Propanolamines
  • Xamoterol
  • Isoproterenol
  • Norepinephrine
Topics
  • Adrenergic beta-Agonists (therapeutic use)
  • Aged
  • Blood Pressure (drug effects)
  • Blood Pressure Monitors
  • Circadian Rhythm
  • Heart Rate (drug effects)
  • Humans
  • Isoproterenol
  • Male
  • Middle Aged
  • Monitoring, Physiologic
  • Norepinephrine (blood)
  • Osmolar Concentration
  • Posture
  • Propanolamines (therapeutic use)
  • Shy-Drager Syndrome (diagnosis, drug therapy, physiopathology)
  • Xamoterol

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: